Literature DB >> 24048167

A novel nonsense mutation in the EpCAM gene in a patient with congenital tufting enteropathy.

Cornelia Thoeni1, Achiya Amir, Conghui Guo, S Zhang, Yaron Avitzur, Y M Heng, Ernest Cutz, Aleixo M Muise.   

Abstract

OBJECTIVES: Tufting enteropathy (TE) is a classical congenital disorder of the intestinal mucosa causing protracted diarrhea in infancy as a result of a dysfunctional epithelial cell barrier, which is mainly caused by mutations in the EpCAM gene and expression of a nonfunctional epithelial cell adhesion molecule in the intestine. We report here a novel nonsense mutation in a patient suspected of having TE, resulting in a complete absence of EpCAM in duodenal enterocytes.
METHODS: A patient presenting with congenital diarrhea and suspected of having TE was screened for EpCAM mutations, and duodenal biopsies were stained for EpCAM using immunohistochemistry analysis.
RESULTS: We identified a novel homozygous nonsense mutation in the EpCAM gene in a patient suspected of having TE, causing a complete loss of EpCAM expression in duodenal enterocytes.
CONCLUSIONS: With screening analysis for EpCAM mutations and immunohistochemistry for EpCAM expression in duodenal enterocytes, we found a novel homozygous mutation in a patient with classical protracted diarrhea in infancy finally diagnosed as TE, which results in a complete absence of EpCAM and in dysfunctional barrier formation in duodenal enterocytes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24048167     DOI: 10.1097/MPG.0000000000000106

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  8 in total

1.  Multilabel immunofluorescence and antigen reprobing on formalin-fixed paraffin-embedded sections: novel applications for precision pathology diagnosis.

Authors:  Jie Pan; Cornelia Thoeni; Aleixo Muise; Herman Yeger; Ernest Cutz
Journal:  Mod Pathol       Date:  2016-03-04       Impact factor: 7.842

2.  Mutations in Plasmalemma Vesicle Associated Protein Result in Sieving Protein-Losing Enteropathy Characterized by Hypoproteinemia, Hypoalbuminemia, and Hypertriglyceridemia.

Authors:  Abdul Elkadri; Cornelia Thoeni; Sophie J Deharvengt; Ryan Murchie; Conghui Guo; James D Stavropoulos; Christian R Marshall; Paul Wales; Robert Bandsma; Ernest Cutz; Chaim M Roifman; David Chitayat; Yaron Avitzur; Radu V Stan; Aleixo M Muise
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-07

3.  Identification of EPCAM mutation: clinical use of microarray.

Authors:  Queenie K-G Tan; Diana M Cardona; Catherine W Rehder; Marie T McDonald
Journal:  Clin Case Rep       Date:  2017-05-10

4.  EPCAM mutation update: Variants associated with congenital tufting enteropathy and Lynch syndrome.

Authors:  Sagar J Pathak; James L Mueller; Kevin Okamoto; Barun Das; Jozef Hertecant; Lynn Greenhalgh; Trevor Cole; Vered Pinsk; Baruch Yerushalmi; Odul E Gurkan; Michael Yourshaw; Erick Hernandez; Sandy Oesterreicher; Sandhia Naik; Ian R Sanderson; Irene Axelsson; Daniel Agardh; C Richard Boland; Martin G Martin; Christopher D Putnam; Mamata Sivagnanam
Journal:  Hum Mutat       Date:  2018-11-29       Impact factor: 4.878

5.  Mutation of EpCAM leads to intestinal barrier and ion transport dysfunction.

Authors:  Philip A Kozan; Matthew D McGeough; Carla A Peña; James L Mueller; Kim E Barrett; Ronald R Marchelletta; Mamata Sivagnanam
Journal:  J Mol Med (Berl)       Date:  2014-12-09       Impact factor: 4.599

6.  Plasmalemma Vesicle Associated Protein Truncation Causes Lethal Protein-Losing Enteropathy in Humans.

Authors:  Ryotaro Sakamori; Lanjing Zhang; Nan Gao
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-07

Review 7.  Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states.

Authors:  David G Levitt; Michael D Levitt
Journal:  Clin Exp Gastroenterol       Date:  2017-07-17

Review 8.  Current View on EpCAM Structural Biology.

Authors:  Aljaž Gaber; Brigita Lenarčič; Miha Pavšič
Journal:  Cells       Date:  2020-05-31       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.